Infammasomes provide a therapeutic target against human diseases

The structure of inflammasomes and their role in diseases.

States Making Progress Toward Setting Payment Limits for Some Drugs

As drug prices continue to rise, some states are fighting back through the use of prescription drug affordability boards (PDABs), which usually set limits on

November 22, 2023

Study highlights risks of high-dose naloxone in opioid overdose response

Whether regular distribution of two intravenous or intramuscular administrations of low-dose naloxone was effective and adequate in reversing opioid overdoses.

September 4, 2023

Jay Bradner, former Novartis research leader, to head up Amgen’s scientific efforts

Jay Bradner, a former top research leader at Novartis, is joining Amgen as its new chief scientific officer, the California company announced Thursday. Bradner is

December 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.